Yahoo Web Search

Search results

    • Q1 2024 Humacyte Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 7 days ago

      Results from our V007 Phase 3 trial of the HAV in patients with end-stage renal disease remain on track to be reported in the third quarter of 2024. As a reminder, we completed enrollment ...